Sami Corwin
Stock Analyst at William Blair
(4.36)
# 1,343
Out of 5,133 analysts
440
Total ratings
44.8%
Success rate
9.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sami Corwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALEC Alector | Rated: Hold | n/a | $2.54 | - | 1 | Sep 23, 2026 | |
| LEGN Legend Biotech | Rated: Hold | n/a | $17.50 | - | 19 | Sep 23, 2026 | |
| NKTX Nkarta | Rated: Hold | n/a | $1.19 | - | 16 | Sep 23, 2026 | |
| RCKT Rocket Pharmaceuticals | Rated: Hold | n/a | $2.30 | - | 24 | Sep 23, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Hold | n/a | $16.08 | - | 15 | Sep 18, 2026 | |
| OBX Obsidian Therapeutics | Initiated Coverage: Buy | $43 | $12.56 | +242.36% | 1 | Sep 9, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | n/a | $20.03 | - | 12 | Sep 9, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | n/a | $22.83 | - | 31 | Sep 8, 2026 | |
| QURE uniQure | Initiated Coverage: Buy | $73 | $23.81 | +206.59% | 30 | Sep 2, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Hold | n/a | $57.23 | - | 15 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $42.24 | - | 21 | Aug 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.8387 | - | 29 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.28 | - | 28 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.05 | - | 13 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $23.93 | - | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $6.84 | - | 20 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.3492 | - | 16 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.08 | - | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $305.23 | - | 20 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $16.62 | +12.82% | 1 | May 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.07 | - | 20 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $63.49 | - | 41 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.65 | n/a | 15 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.27 | n/a | 5 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.10 | n/a | 4 | Feb 1, 2023 |
Alector
Sep 23, 2026
Rated: Hold
Price Target: n/a
Current: $2.54
Upside: -
Legend Biotech
Sep 23, 2026
Rated: Hold
Price Target: n/a
Current: $17.50
Upside: -
Nkarta
Sep 23, 2026
Rated: Hold
Price Target: n/a
Current: $1.19
Upside: -
Rocket Pharmaceuticals
Sep 23, 2026
Rated: Hold
Price Target: n/a
Current: $2.30
Upside: -
Ultragenyx Pharmaceutical
Sep 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $16.08
Upside: -
Obsidian Therapeutics
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $12.56
Upside: +242.36%
Tyra Biosciences
Sep 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $20.03
Upside: -
Beam Therapeutics
Sep 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.83
Upside: -
uniQure
Sep 2, 2026
Initiated Coverage: Buy
Price Target: $73
Current: $23.81
Upside: +206.59%
BioMarin Pharmaceutical
Aug 31, 2026
Reiterated: Hold
Price Target: n/a
Current: $57.23
Upside: -
Aug 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $42.24
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.8387
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.28
Upside: -
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.05
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $23.93
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.84
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.3492
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.08
Upside: -
Aug 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $305.23
Upside: -
May 2, 2026
Initiated Coverage: Buy
Price Target: $19
Current: $16.62
Upside: +12.82%
Feb 26, 2026
Reiterated: Hold
Price Target: n/a
Current: $16.07
Upside: -
Feb 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $63.49
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $1.65
Upside: n/a
Dec 22, 2023
Rated: Hold
Price Target: n/a
Current: $13.27
Upside: n/a
Feb 1, 2023
Reiterated: Buy
Price Target: n/a
Current: $4.10
Upside: n/a